Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

Compare

14.53

-0.12 (-0.82%)

At close: Jan 30, 2026, 4:00 PM EST

14.24

-0.29 (-2.00%)

After-hours: Jan 30, 2026, 7:20 PM EST

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	72.89	83.4	48.76	94.09	231.64	272.35
Short-Term Investments	278.62	275.04	301.61	295.22	234.18	125.98
Cash & Short-Term Investments	351.51	358.44	350.37	389.31	465.82	398.33
Cash Growth	0.94%	2.30%	-10.00%	-16.43%	16.94%	30.16%
Accounts Receivable	30.73	36.54	24.09	13.48	15.41	-
Other Receivables	0.2	0.6	0.7	1.1	-	-
Receivables	30.93	37.14	24.79	14.58	15.41	-
Inventory	44.79	39.23	39.71	24.75	19.33	13.93
Prepaid Expenses	11.11	11.22	9.49	13.58	11.71	5.76
Restricted Cash	0.3	0.04	0.12	0.08	0.26	-
Other Current Assets	0.1	0.53	0.33	0.23	0.8	1.42
Total Current Assets	438.74	446.6	424.8	442.54	513.32	419.43
Property, Plant & Equipment	84.8	98.87	116.57	8.56	9.8	10.28
Long-Term Investments	-	-	0.2	-	-	24.38
Other Intangible Assets	3.9	4.36	4.98	6.43	8.4	9.33
Other Long-Term Assets	0.09	0.82	1.52	13.34	11.84	0.25
Total Assets	527.53	550.65	548.06	470.86	543.37	463.66
Accounts Payable	2.21	5.19	4.33	3.09	3.88	2.64
Accrued Expenses	49.32	54.12	50.06	36.28	30.25	22.16
Current Portion of Leases	17.37	15.07	15.6	0.94	1.06	0.79
Current Income Taxes Payable	-	-	-	0.63	0.81	-
Current Unearned Revenue	4.6	11	4.81	3.15	0.19	-
Other Current Liabilities	2.72	12.39	2.39	2.03	4.45	6.41
Total Current Liabilities	76.22	97.76	77.19	46.11	40.65	32
Long-Term Leases	60.85	64.3	82.01	7.15	7.68	7.62
Long-Term Unearned Revenue	12.25	-	-	-	-	-
Other Long-Term Liabilities	12.44	11.11	10.91	12.17	15.95	16.3
Total Liabilities	161.76	173.17	170.11	65.43	64.28	55.91
Common Stock	1,117	1,188	1,200	1,185	1,177	944.33
Additional Paid-In Capital	109.89	127	120.79	85.49	59.01	39.38
Retained Earnings	-860.16	-936.57	-942.32	-864.3	-756.12	-575.16
Comprehensive Income & Other	-0.75	-0.65	-0.73	-1.06	-0.85	-0.81
Shareholders' Equity	365.77	377.48	377.95	405.44	479.09	407.75
Total Liabilities & Equity	527.53	550.65	548.06	470.86	543.37	463.66
Total Debt	78.21	79.37	97.61	8.09	8.74	8.41
Net Cash (Debt)	273.3	279.07	252.76	381.22	457.08	389.92
Net Cash Growth	4.96%	10.41%	-33.70%	-16.60%	17.22%	27.42%
Net Cash Per Share	1.93	1.91	1.76	2.69	3.53	3.29
Filing Date Shares Outstanding	131.84	137.34	144.62	142.58	141.65	127.45
Total Common Shares Outstanding	131.84	140.88	143.83	142.27	141.6	126.73
Working Capital	362.52	348.83	347.61	396.43	472.68	387.43
Book Value Per Share	2.77	2.68	2.63	2.85	3.38	3.22
Tangible Book Value	361.87	373.12	372.98	399.01	470.69	398.42
Tangible Book Value Per Share	2.74	2.65	2.59	2.80	3.32	3.14
Machinery	2.02	2.02	2.02	1.87	1.88	0.46
Construction In Progress	-	-	-	0.26	0.39	4.47
Leasehold Improvements	3.24	3.24	3.24	2.98	2.98	0.03

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q